Clinical Trial Update: Pharmacokinetic Comparison Of All FK-506 Formulations [Phase 3]

View source ↗

Summary

Phase 3 pharmacokinetic comparison evaluated all tacrolimus (FK-506) formulations in patients with renal failure; results were posted in January 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Failure

Drugs mentioned

• Tacrolimus (FK-506) (Tacrolimus)

Snippet

Sponsor: Veloxis Pharmaceuticals | Conditions: Renal Failure | Phase 3 | Status: COMPLETED | Results posted: 2016-01-18